136 related articles for article (PubMed ID: 38151421)
41. iRhom2 controls the substrate selectivity of stimulated ADAM17-dependent ectodomain shedding.
Maretzky T; McIlwain DR; Issuree PD; Li X; Malapeira J; Amin S; Lang PA; Mak TW; Blobel CP
Proc Natl Acad Sci U S A; 2013 Jul; 110(28):11433-8. PubMed ID: 23801765
[TBL] [Abstract][Full Text] [Related]
42. iRhoms 1 and 2 are essential upstream regulators of ADAM17-dependent EGFR signaling.
Li X; Maretzky T; Weskamp G; Monette S; Qing X; Issuree PD; Crawford HC; McIlwain DR; Mak TW; Salmon JE; Blobel CP
Proc Natl Acad Sci U S A; 2015 May; 112(19):6080-5. PubMed ID: 25918388
[TBL] [Abstract][Full Text] [Related]
43. The iRhom2/ADAM17 Axis Attenuates Bacterial Uptake by Phagocytes in a Cell Autonomous Manner.
Seifert A; Wozniak J; Düsterhöft S; Kasparek P; Sedlacek R; Dreschers S; Orlikowsky TW; Yildiz D; Ludwig A
Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32825187
[TBL] [Abstract][Full Text] [Related]
44. iRhom2 loss alleviates renal injury in long-term PM2.5-exposed mice by suppression of inflammation and oxidative stress.
Chenxu G; Minxuan X; Yuting Q; Tingting G; Jinxiao L; Mingxing W; Sujun W; Yongjie M; Deshuai L; Qiang L; Linfeng H; Jun T
Redox Biol; 2018 Oct; 19():147-157. PubMed ID: 30165303
[TBL] [Abstract][Full Text] [Related]
45. Diosgenin inhibits ER stress-induced inflammation in aorta via iRhom2/TACE mediated signaling in experimental diabetic rats: An in vivo and in silico approach.
Prasad M; Jayaraman S; Rajagopal P; Veeraraghavan VP; Kumar PK; Piramanayagam S; Pari L
Chem Biol Interact; 2022 May; 358():109885. PubMed ID: 35305976
[TBL] [Abstract][Full Text] [Related]
46. The Role of iRhom2 in Metabolic and Cardiovascular-Related Disorders.
Geesala R; Issuree PD; Maretzky T
Front Cardiovasc Med; 2020; 7():612808. PubMed ID: 33330676
[TBL] [Abstract][Full Text] [Related]
47. Lysophosphatidic acid induces tumor necrosis factor-alpha to regulate a pro-inflammatory cytokine network in ovarian cancer.
Wang W; Wu J; Mukherjee A; He T; Wang XY; Ma Y; Fang X
FASEB J; 2020 Oct; 34(10):13935-13948. PubMed ID: 32851734
[TBL] [Abstract][Full Text] [Related]
48. The ADAM17 sheddase complex regulator iTAP/Frmd8 modulates inflammation and tumor growth.
Badenes M; Burbridge E; Oikonomidi I; Amin A; de Carvalho É; Kosack L; Mariano C; Domingos P; Faísca P; Adrain C
Life Sci Alliance; 2023 Apr; 6(4):. PubMed ID: 36720499
[TBL] [Abstract][Full Text] [Related]
49. Activated iRhom2 drives prolonged PM
Xu MX; Qin YT; Ge CX; Gu TT; Lou DS; Li Q; Hu LF; Li YY; Yang WW; Tan J
Nanotoxicology; 2018 Nov; 12(9):1045-1067. PubMed ID: 30257117
[TBL] [Abstract][Full Text] [Related]
50. iRHOM2: A Regulator of Palmoplantar Biology, Inflammation, and Viral Susceptibility.
Chao-Chu J; Murtough S; Zaman N; Pennington DJ; Blaydon DC; Kelsell DP
J Invest Dermatol; 2021 Apr; 141(4):722-726. PubMed ID: 33080304
[TBL] [Abstract][Full Text] [Related]
51. Histamine antagonizes tumor necrosis factor (TNF) signaling by stimulating TNF receptor shedding from the cell surface and Golgi storage pool.
Wang J; Al-Lamki RS; Zhang H; Kirkiles-Smith N; Gaeta ML; Thiru S; Pober JS; Bradley JR
J Biol Chem; 2003 Jun; 278(24):21751-60. PubMed ID: 12646554
[TBL] [Abstract][Full Text] [Related]
52. ROS-mediated liposomal dexamethasone: a new FA-targeted nanoformulation to combat rheumatoid arthritis
Song Y; Ismail M; Shan Q; Zhao J; Zhu Y; Zhang L; Du Y; Ling L
Nanoscale; 2021 Dec; 13(47):20170-20185. PubMed ID: 34846489
[TBL] [Abstract][Full Text] [Related]
53. B cell activating factor-dependent expression of vascular endothelial growth factor in MH7A human synoviocytes stimulated with tumor necrosis factor-α.
Lee GH; Lee J; Lee JW; Choi WS; Moon EY
Int Immunopharmacol; 2013 Sep; 17(1):142-7. PubMed ID: 23684916
[TBL] [Abstract][Full Text] [Related]
54. Porcine reproductive and respiratory syndrome virus infection activates ADAM17 to induce inflammatory responses.
Liu J; Su G; Duan C; Sun Z; Xiao S; Zhou Y; Fang L
Vet Microbiol; 2024 May; 292():110066. PubMed ID: 38555788
[TBL] [Abstract][Full Text] [Related]
55. Macrocyclic θ-defensins suppress tumor necrosis factor-α (TNF-α) shedding by inhibition of TNF-α-converting enzyme.
Schaal JB; Maretzky T; Tran DQ; Tran PA; Tongaonkar P; Blobel CP; Ouellette AJ; Selsted ME
J Biol Chem; 2018 Feb; 293(8):2725-2734. PubMed ID: 29317500
[TBL] [Abstract][Full Text] [Related]
56. A structural model of the iRhom-ADAM17 sheddase complex reveals functional insights into its trafficking and activity.
Kahveci-Türköz S; Bläsius K; Wozniak J; Rinkens C; Seifert A; Kasparek P; Ohm H; Oltzen S; Nieszporek M; Schwarz N; Babendreyer A; Preisinger C; Sedlacek R; Ludwig A; Düsterhöft S
Cell Mol Life Sci; 2023 Apr; 80(5):135. PubMed ID: 37119365
[TBL] [Abstract][Full Text] [Related]
57. ADAM17 orchestrates Interleukin-6, TNFα and EGF-R signaling in inflammation and cancer.
Schumacher N; Rose-John S
Biochim Biophys Acta Mol Cell Res; 2022 Jan; 1869(1):119141. PubMed ID: 34610348
[TBL] [Abstract][Full Text] [Related]
58. Microparticles of human atherosclerotic plaques enhance the shedding of the tumor necrosis factor-alpha converting enzyme/ADAM17 substrates, tumor necrosis factor and tumor necrosis factor receptor-1.
Canault M; Leroyer AS; Peiretti F; Lesèche G; Tedgui A; Bonardo B; Alessi MC; Boulanger CM; Nalbone G
Am J Pathol; 2007 Nov; 171(5):1713-23. PubMed ID: 17872973
[TBL] [Abstract][Full Text] [Related]
59. Novel functions of inactive rhomboid proteins in immunity and disease.
Geesala R; Issuree PD; Maretzky T
J Leukoc Biol; 2019 Oct; 106(4):823-835. PubMed ID: 31369701
[TBL] [Abstract][Full Text] [Related]
60. iRhoms; Its Functions and Essential Roles.
Lee MY; Nam KH; Choi KC
Biomol Ther (Seoul); 2016 Mar; 24(2):109-14. PubMed ID: 26869525
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
